McMaster University
Investigating the role of microbial protein metabolism in intestinal inflammation
Abstract
dc:description.abstractThe gut microbiota plays a central role in regulating host metabolism and influences epithelial barrier function, immune responses, and intestinal inflammation. Altered host-microbe interactions have been associated with inflammatory bowel disease (IBD), and microbial metabolism is strongly influenced by diet. IBD patients often identify diet as a major factor driving symptom severity. While fibre metabolism has been extensively investigated, less is understood regarding protein metabolism and its contribution to intestinal inflammation. Western diets are often high in protein, and microbial protein metabolism generates bioactive metabolites that may influence intestinal homeostasis and inflammation through pathways such as mechanistic target of rapamycin complex 1 (mTORC1) signalling. Therefore, this thesis investigated how microbial composition, dietary protein, and intestinal inflammation influence amino acid availability, microbial metabolite production, and mTORC1 signalling. Using gnotobiotic mouse models with different microbial complexity, we observed that intestinal microbiota plays an important role in protein metabolism and metabolite production. Germ-free mice exhibited increased luminal amino acid availability, including mTORC1-activating amino acids such as arginine and branched-chain amino acids, alongside elevated mTORC1 activation. In contrast, mice colonized with complex microbiota exhibited enhanced metabolism of amino acids into bioactive metabolites and reduced mTORC1 signalling. Dietary protein enrichment further enhanced these effects, highlighting the key role of microbiota in dietary protein utilization. In a chemically induced colitis model, intestinal inflammation was associated with altered microbiota composition, disrupted protein metabolism, increased amino acid and arginine-derived metabolite production, and enhanced mTORC1 activation. Similarly, IBD patients exhibited altered microbiota composition and fecal metabolomic profiles, including increased mTORC1-activating amino acids and arginine-derived metabolites, with consistent trends observed in repository data. Together, these findings identify the gut microbiota as a key regulator of protein metabolism that can influence colonic mTORC1 signalling and intestinal inflammation, highlighting microbial protein metabolism as a potential target for management strategies in IBD.
Degree
thesis:*- Department dc:contributor.department
- Medical Sciences
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Beaudoin, Kayla
- Advisor dc:contributor.advisor
-
- Caminero, Alberto
Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- https://doi.org/10.71548/173